Advanced search

  • Ginekologia Polska
  • Online first Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
Online first
Research paper
Published online: 2024-12-18

open access

View PDF Download PDF file
Page views 1
Article views/downloads 0
Get Citation

Connect on Social Media

Connect on Social Media

Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism

Izabela Uzar1, Anna Bogacz2, Elzbieta Sowinska-Przepiera3, Anhelli Syrenicz3, Adam Kaminski4, Marlena Wolek2, Bogusław Czerny12

Abstract

Objectives: Hyperandrogenism is a frequently recognized endocrine imbalance in which there is excessive production of androgens. The purpose of the study was to investigate the impact of vitamin D receptor (VDR) gene polymorphisms on chosen bone metabolism and biochemical parameters in women with hyperandrogenism.

Material and methods: Eighty young females with hyperandrogenism were enrolled in the study, in whom selected parameters of bone turnover, endocrine and metabolic parameters were determined. Two polymorphisms of the VDR gene were analyzed: rs731236 (TaqI) and rs1544410 (BsmI), using real-time polymerase chain reaction (PCR). Statistical tests were performed in this research with the program SPSS Statistics 17.0 for Windows.

Results: The rs731236 and rs1544410 polymorphisms of the VDR gene turned out to be statistically significantly related to the concentration of insulin determined in the 60 'glucose tolerance test. There was no relationship between the studied polymorphisms of the VDR gene and the determined parameters of bone metabolism and other biochemical parameters.

Conclusions: The research presented that VDR gene variants may influence disturbances in carbohydrate metabolism in young women with hyperandrogenism.

Keywords: hyperandrogenismVDR polymorphismsbone metabolismbiomarkershormonal parameters

Article available in PDF format

View PDF Download PDF file

References

  1. Sowińska-epiera E, Niedzielska M. Hiperandrogenism in women as a clinical diagnosthic and therapeutical problem. Prz Lek. 2018; 75(8): 405–410.
  2. Carmina E, Rosato F, Jannì A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006; 91(1): 2–6.
    CrossRefPubMed
  3. Sanchón R, Gambineri A, Alpañés M, et al. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod. 2012; 27(4): 1209–1216.
    CrossRefPubMed
  4. Carmina E. Ovarian and adrenal hyperandrogenism. Ann N Y Acad Sci. 2006; 1092: 130–137.
    CrossRefPubMed
  5. Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article. Eur J Obstet Gynecol Reprod Biol X. 2019; 8(3): 100060.
    CrossRefPubMed
  6. Unluhizarci K, Kaltsas G, Kelestimur F. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest. 2012; 42(1): 86–94.
    CrossRefPubMed
  7. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016; 37(5): 467–520.
    CrossRefPubMed
  8. Wehr E, Trummer O, Giuliani A, et al. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011; 164(5): 741–749.
    CrossRefPubMed
  9. Muscogiuri G, Altieri B, de Angelis C, et al. Shedding new light on female fertility: the role of vitamin D. Rev Endocr Metab Disord. 2017; 18(3): 273–283.
    CrossRefPubMed
  10. Jukic AM, Steiner AZ, Baird DD. Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women. Menopause. 2015; 22(3): 312–316.
    CrossRefPubMed
  11. Song DoK, Lee H, Hong YS, et al. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study. BMC Endocr Disord. 2019; 19(1): 145.
    CrossRefPubMed
  12. Parikh G, Varadinova M, Suwandhi P, et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res. 2010; 42(10): 754–757.
    CrossRefPubMed
  13. Vulcan T, Filip GA, Lenghel LM, et al. Polymorphisms of vitamin D receptor and the effect on metabolic and endocrine abnormalities in polycystic ovary syndrome: a review. Horm Metab Res. 2021; 53(10): 645–653.
    CrossRefPubMed
  14. Al Thomali A, Daghestani MH, Daghestani MH, et al. Polymorphic variations in VDR gene in saudi women with and without polycystic ovary syndrome (PCOS) and significant influence of seven polymorphic sites on anthropometric and hormonal parameters. J Med Biochem. 2018; 37(4): 415–425.
    CrossRefPubMed
  15. Ortiz-Flores AE, Martínez-García MÁ, Nattero-Chávez L, et al. Iron overload in functional hyperandrogenism: in a randomized trial, bloodletting does not improve metabolic outcomes. J Clin Endocrinol Metab. 2021; 106(4): e1559–e1573.
    CrossRefPubMed
  16. Luque-Ramírez M, Ortiz-Flores AE, Martínez-García MÁ, et al. Effect of iron depletion by bloodletting vs. observation on oxidative stress biomarkers of women with functional hyperandrogenism taking a combined oral contraceptive: a randomized clinical trial. J Clin Med. 2022; 11(13): 3864–3880.
    CrossRefPubMed
  17. Shuhart CR, Yeap SS, Anderson PA, et al. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom. 2019; 22(4): 453–471.
    CrossRefPubMed
  18. Xavier LB, Gontijo NA, Rodrigues KF, et al. Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women. Gynecol Endocrinol. 2019; 35(2): 146–149.
    CrossRefPubMed
  19. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92(6): 2017–2029.
    CrossRefPubMed
  20. Rodrigues KF, Pietrani NT, Bosco AA, et al. Lower vitamin D levels, but not VDR polymorphisms, influence type 2 diabetes mellitus in brazilian population independently of obesity. Medicina (Kaunas). 2019; 55(5): 188.
    CrossRefPubMed
  21. Mayer O, Seidlerová J, Černá V, et al. Serum vitamin D status, vitamin D receptor polymorphism, and glucose homeostasis in healthy subjects. Horm Metab Res. 2018; 50(1): 56–64.
    CrossRefPubMed
  22. Shaat N, Katsarou A, Shahida B, et al. Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus. PLoS One. 2020; 15(5): e0232297.
    CrossRefPubMed
  23. Rahmadhani R, Zaharan NL, Mohamed Z, et al. The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country. PLoS One. 2017; 12(6): e0178695.
    CrossRefPubMed
  24. Han FF, Lv YL, Gong LL, et al. VDR Gene variation and insulin resistance related diseases. Lipids Health Dis. 2017; 16(1): 157.
    CrossRefPubMed
  25. Apaydın M, Beysel S, Eyerci N, et al. The VDR gene FokI polymorphism is associated with gestational diabetes mellitus in Turkish women. BMC Med Genet. 2019; 20(1): 82.
    CrossRefPubMed
  26. Guraya SS, Alhussaini KA, Shaqrun FM, et al. Correlation of clinical, radiological and serum analysis of hypovitaminosis D with polycystic ovary syndrome: A systematic review and meta-analysis. J Taibah Univ Med Sci. 2017; 12(4): 277–283.
    CrossRefPubMed
  27. Zeng X, Xie YJ, Liu YT, et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020; 502: 214–221.
    CrossRefPubMed
  28. Otto-Buczkowska E, Grzyb K, Jainta N. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty. Pediatr Endocrinol Diabetes Metab. 2018; 24(1): 40–44.
    CrossRefPubMed
  29. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016; 37(5): 467–520.
    CrossRefPubMed
  30. Talaei A, Adgi Z, Mohamadi Kelishadi M. Idiopathic hirsutism and insulin resistance. Int J Endocrinol. 2013; 2013: 593197.
    CrossRefPubMed
  31. Santos BR, Lecke SB, Spritzer PM. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study. Reprod Biol Endocrinol. 2018; 16(1): 38.
    CrossRefPubMed
  32. Di Bari F, Catalano A, Bellone F, et al. Vitamin D, bone metabolism, and fracture risk in polycystic ovary syndrome. Metabolites. 2021; 11(2).
    CrossRefPubMed
  33. Krul-Poel YHM, Snackey C, Louwers Y, et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. Eur J Endocrinol. 2013; 169(6): 853–865.
    CrossRefPubMed
  34. Niu YM, Wang YD, Jiang GB, et al. Association between vitamin D receptor gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis. Front Physiol. 2019; 10(9): 1902.
    CrossRefPubMed
  35. Jedrzejuk D, Łaczmański Ł, Milewicz A, et al. Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case-control study of lower Silesian women. Gynecol Endocrinol. 2015; 31(12): 976–979.
    CrossRefPubMed
  36. Dasgupta S, Dutta J, Annamaneni S, et al. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J Med Res. 2015; 142(3): 276–285.
    CrossRefPubMed
  37. Bander D, Parczewski M, Urbańska A, et al. Osteoporosis associated selected single nucleotide polymorphisms frequency in HIV-infected and non-infected Polish population. Endokrynol Pol. 2017; 68(5): 541–549.
    CrossRef
  38. Seremak-Mrozikiewicz A, Drews K, Mrozikiewicz PM, et al. Correlation of vitamin D receptor gene (VDR) polymorphism with osteoporotic changes in Polish postmenopausal women. Neuro Endocrinol Lett. 2009; 30(4): 540–546.
    PubMed
  39. Shen H, Xie J, Lu H. Vitamin D receptor gene and risk of fracture in postmenopausal women: a meta-analysis. Climacteric. 2014; 17(4): 319–324.
    CrossRefPubMed
  40. Stathopoulou MG, Dedoussis GVZ, Trovas G, et al. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake. J Nutr Biochem. 2011; 22(8): 752–757.
    CrossRefPubMed
  41. Zintzaras E, Rodopoulou P, Koukoulis GN. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Dis Markers. 2006; 22(5–6): 317–326.
    CrossRefPubMed
  42. Banjabi AA, Al-Ghafari AB, Kumosani TA, et al. Genetic influence of vitamin D receptor gene polymorphisms on osteoporosis risk. Int J Health Sci (Qassim). 2020; 14(4): 22–28.
    PubMed
  43. Ahmad I, Jafar T, Mahdi F, et al. Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women. Gene. 2018; 659(4): 123–127.
    CrossRefPubMed
  44. Douroudis K, Tarassi K, Ioannidis G, et al. Association of vitamin D receptor gene polymorphisms with bone mineral density in postmenopausal women of Hellenic origin. Maturitas. 2003; 45(3): 191–197.
    CrossRefPubMed
  45. Ranjzad F, Mahban A, Shemirani AI, et al. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet. 2011; 28(3): 225–232.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note